A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years

NCT04531462 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Empagliflozin
DRUG: Placebo

Sponsor

Boehringer Ingelheim